Cost Effectiveness Analysis Of Tenofovir Disoproxil Fumarate (Viread®) In The Treatment Of Patients With Chronic Hepatitis B (Chb) In Mexico
May 1, 2013, 00:00
10.1016/j.jval.2013.03.1085
https://www.valueinhealthjournal.com/article/S1098-3015(13)01156-X/fulltext
Title :
Cost Effectiveness Analysis Of Tenofovir Disoproxil Fumarate (Viread®) In The Treatment Of Patients With Chronic Hepatitis B (Chb) In Mexico
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01156-X&doi=10.1016/j.jval.2013.03.1085
First page :
A214
Section Title :
Gastrointestinal Disorders
Open access? :
No
Section Order :
653